Belite Bio Reports Non-GAAP EPS of -$0.34, Exceeding Expectations
Belite Bio (BLTE) reported a non-GAAP earnings per share loss of $0.34 for Q1 2026, which beat expectations by $0.30. The company also disclosed cash and equivalents totaling $276.4 million as of March 31, 2026.
Tickers: $BLTE
Topics: Earnings Financials